{"id":"NCT01324947","sponsor":"Celgene","briefTitle":"Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma","officialTitle":"Open-label, Multi-center, Single Arm Study For The Safety And Efficacy Of Pomalidomide Monotherapy For Subjects With Refractory Or Relapsed And Refractory Multiple Myeloma. A Companion Study For Clinical Trial CC-4047-MM003","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-03-01","primaryCompletion":"2014-07-31","completion":"2014-07-31","firstPosted":"2011-03-29","resultsPosted":"2015-07-30","lastUpdate":"2019-11-19"},"enrollment":74,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Myeloma"],"interventions":[{"type":"DRUG","name":"pomalidomide","otherNames":["CC-4047"]}],"arms":[{"label":"Pomalidomide","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of pomalidomide monotherapy in subjects with refractory or relapsed and refractory multiple myeloma who were enrolled in study CC-4047-MM-003 (NCT01311687) and discontinued treatment with high-dose dexamethasone due to disease progression.","primaryOutcome":{"measure":"Percentage of Participants With an Objective Response According to International Myeloma Working Group (IMWG) Uniform Response Criteria Based on Investigator Assessment","timeFrame":"From randomization through the study follow-up phase; up to the data cut-off of 31 July 2014; Maximum time on follow-up was 141.1 weeks.","effectByArm":[{"arm":"Pomalidomide","deltaMin":23,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":1},"locations":{"siteCount":91,"countries":["Australia","Belgium","Canada","Czechia","Denmark","France","Germany","Greece","Italy","Netherlands","Russia","Spain","Sweden","Switzerland","United Kingdom"]},"refs":{"pmids":["27173785","24007748","25403264"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":52,"n":73},"commonTop":["Anaemia","Neutropenia","Thrombocytopenia","Fatigue","Constipation"]}}